Novartis is buying dry-eye medicine brand ‘Xiidra’ from Takeda Pharmaceutical for up to $5.3 billion as the Swiss pharma-maker refreshes its ophthalmic medicines portfolio with a potential blockbuster. The deal calls for $3.4 billion up front and milestone payments up to $1.9 billion, Novartis said.
The Department of Health-Abu Dhabi decided to withdraw 20 batches medical products used in catheterisation and other healthcare operations from the Emirate because of their possibility of causing serious infection to patients if they were not immediately substituted with good ones.
Stem cells are magic that need follow-up for best results, says Dr Steven Victor, an American Board Certified Specialist in Regenerative Medicine and Regenerative Cosmetic Dermatology, in an exclusive Facebook Live interview with Gulf Today.
Despite strong legislations, India still grapples with the malaise of counterfeit medicines being sold in the open market and online. In fact I recently came across a report which said that about 20 per cent of the drugs manufactured in India are adulterated. It is an unhealthy prognosis but apart from that India